chr	position	beta	se	p	n	id	rsid	ea	nea	eaf	trait	gene	nsnps	PP.H0.abf	PP.H1.abf	PP.H2.abf	PP.H3.abf	PP.H4.abf	lead_snp
5	151194713	-0.426577	0.0115228	5.33335e-300	31568	eqtl-a-ENSG00000177556	rs4629586	A	C	0.417431	ENSG00000177556	ATOX1	645	1.66989368138667e-308	6.84066577395269e-296	2.43812138020335e-17	0.0373506947840088	0.962649305215981	rs7720579
5	151194713	-0.344677	0.0117153	2.94442e-190	5501	eqtl-a-ENSG00000213433	rs4629586	A	C	0.417431	ENSG00000213433	ATOX1	590	1.53989412281074e-304	2.41698624059352e-289	6.36891640215598e-16	0.999651711127007	0.000348288873029212	rs17741826
5	151194713	-0.23582	0.0119049	2.49977e-87	3831	eqtl-a-ENSG00000253921	rs4629586	A	C	0.417431	ENSG00000253921	ATOX1	534	3.83495091563297e-100	6.01920297377472e-85	6.34940723614766e-16	0.996577022465211	0.00342297753478389	rs2915823
5	151194713	0.124217	0.0120238	5.11329e-25	3831	eqtl-a-ENSG00000254226	rs4629586	A	C	0.417431	ENSG00000254226	ATOX1	534	9.55982104166785e-47	1.50047561256108e-31	6.37001865932249e-16	0.999815356695006	0.000184643304999587	rs2016409
5	151194713	-0.012251	0.0019	1.17001e-10	531774	ebi-a-GCST90002369	rs4629586	A	C	0.414705	Red cell distribution width	ATOX1							
5	151194713	-0.0117279	0.00198263	2.80001e-09	514929	ebi-a-GCST90029001	rs4629586	A	C	0.415761	Red cell distribution width	ATOX1							
5	151194713	-0.0123225	0.00215227	1e-08	408112	ebi-a-GCST90002404	rs4629586	A	C	0.415723	Red cell distribution width	ATOX1							
5	151194713	-0.043819	0.0080455	5.17726e-08		ubm-b-3916	rs4629586	A	C	0.41571	rfMRI connectivity ICA-features 3	ATOX1	953	6.35973659840954e-20	0.000107972588979637	5.7252386476838e-17	0.0962967887318275	0.903595238679192	rs10044368
5	151194713	-0.012405	0.00239296	2.1734e-07	350470	ukb-d-30110_irnt	rs4629586	A	C	0.416346	Platelet distribution width	ATOX1							
5	151194713	-0.0113071	0.0021823	2.19999e-07	408112	ebi-a-GCST90002401	rs4629586	A	C	0.415401	Platelet distribution width	ATOX1							
5	151194713	-0.040827	0.0079987	3.34041e-07		ubm-b-1432	rs4629586	A	C	0.41571	wg_rh_intensity-contrast_supramarginal	ATOX1	953	5.57084937257388e-20	9.45792361467948e-05	4.81705032699904e-16	0.817633666064741	0.182271754699111	rs2964613
5	151194713	-0.040642	0.0079988	3.77572e-07		ubm-b-1409	rs4629586	A	C	0.41571	wg_rh_intensity-contrast_inferiorparietal	ATOX1	953	1.30772956868649e-19	0.000222020118335744	3.33520103246336e-16	0.565800621622903	0.433977358258762	rs2964613
1	109817590	0.018837	0.002324	0		ieu-b-4808	rs12740374	T	G	0.223883	25 hydroxyvitamin D level	CELSR2							
1	109817590	0.695915	0.0133745	1.6769889188804e-308	31212	eqtl-a-ENSG00000134222	rs12740374	T	G	0.210449	ENSG00000134222	CELSR2	613	0	0	0	0.284993045009733	0.715006954990361	rs629301
1	109817590	-0.827	0.0267	1.02329e-210	3301	prot-a-1277	rs12740374	T	G	0.22252	Granulins	CELSR2	653	0	4.72689114784906e-201	0	0.00674067362288639	0.993259326377112	rs12740374
1	109817590	-0.1623	0.0063	1.93197e-145	290385	ebi-a-GCST90018989	rs12740374	T	G	0.163415	Medication use (HMG CoA reductase inhibitors)	CELSR2							
1	109817590	-0.6382	0.0282	3.16228e-113	3301	prot-a-303	rs12740374	T	G	0.22252	Complement C1q tumor necrosis factor-related protein 1	CELSR2	653	0	6.24898106531229e-107	0	0.0153401420068715	0.984659857993171	rs629301
1	109817590	-0.2104	0.011	2.99916e-82		finn-b-RX_STATIN	rs12740374	T	G	0.2145	Statin medication	CELSR2	751	0	1.41513127584217e-78	0	0.00558826893923073	0.99441173106088	rs629301
1	109817590	-0.0777907	0.00464452	9.09913e-64		met-d-Sphingomyelins	rs12740374	T	G	0.221071	Sphingomyelins	CELSR2	613	0	3.3911308356898e-06	0	0.00485699198041103	0.995139616888849	rs12740374
1	109817590	-0.0777907	0.00464452	9.09913e-64		met-d-Sphingomyelins	rs12740374	T	G	0.221071	Sphingomyelins	CELSR2	778	0	4.89750376946767e-59	0	0.000662397052784127	0.999337602947301	rs12740374
1	109817590	-0.0772128	0.00464049	3.59998e-62	115006	ebi-a-GCST90092982	rs12740374	T	G	0.221084	Sphingomyelin levels	CELSR2							
1	109817590	-0.0118904	0.000787483	1.59993e-51	462933	ukb-b-11268	rs12740374	T	G	0.221164	Treatment/medication code: simvastatin	CELSR2	783	0	9.95370013299117e-32	0	0.000990871360291671	0.99900912863964	rs12740374
1	109817590	-0.0118904	0.000787483	1.59993e-51	462933	ukb-b-11268	rs12740374	T	G	0.221164	Treatment/medication code: simvastatin	CELSR2	582	0	8.87549842057251e-47	0	0.000717310751251869	0.999282689248769	rs12740374
1	109817590	-0.4269	0.0294	9.54993e-48	3301	prot-a-2284	rs12740374	T	G	0.22252	Group XIIB secretory phospholipase A2-like protein	CELSR2	653	0	4.51059435311585e-43	0	0.00455986800365577	0.9954401319964	rs12740374
1	109817590	-0.20416	0.0144995	4.99804e-45	30463	eqtl-a-ENSG00000116299	rs12740374	T	G	0.210449	ENSG00000116299	CELSR2	613	0	0	0	1	0	rs649539
1	109817590	-0.00576576	0.000425545	8.00018e-42	462933	ukb-b-10008	rs12740374	T	G	0.221164	Treatment/medication code: atorvastatin	CELSR2	783	0	5.6225312612627e-24	0	0.00738085134316532	0.992619148656938	rs12740374
1	109817590	-0.00576576	0.000425545	8.00018e-42	462933	ukb-b-10008	rs12740374	T	G	0.221164	Treatment/medication code: atorvastatin	CELSR2	458	0	6.24966508991275e-37	0	0.00289272031081271	0.997107279689261	rs12740374
1	109817590	0.0312804	0.00235129	3.19963e-40	435516	ebi-a-GCST90025989	rs12740374	T	G	0.221398	Insulin-like growth factor 1 levels	CELSR2							
1	109817590	-0.0116587	0.000926596	2.69215e-36	337159	ukb-a-121	rs12740374	T	G	0.221518	Treatment/medication code: simvastatin	CELSR2	783	0	9.95370013299117e-32	0	0.000990871360291671	0.99900912863964	rs12740374
1	109817590	-0.0116587	0.000926596	2.69215e-36	337159	ukb-a-121	rs12740374	T	G	0.221518	Treatment/medication code: simvastatin	CELSR2	582	0	8.87549842057251e-47	0	0.000717310751251869	0.999282689248769	rs12740374
1	109817590	0.0297407	0.00246724	1.84247e-33	387834	ebi-a-GCST90014008	rs12740374	T	G		IGF 1 (UKB data field 30770)	CELSR2							
1	109817590	-0.00335496	0.000282999	2.02722e-32	1159871	ebi-a-GCST90026654	rs12740374	T	G	0.2146	Estimated glomerular filtration rate (creatinine)	CELSR2							
1	109817590	0.0280957	0.00238103	2.19989e-32	437660	ebi-a-GCST90025946	rs12740374	T	G	0.221363	Creatinine levels	CELSR2							
1	109817590	0.0244	0.0021	5.70033e-30	344104	ebi-a-GCST90018979	rs12740374	T	G	0.176224	Serum creatinine levels	CELSR2							
1	109817590	-0.202908	0.0181007	3.64334e-29	178726	ebi-a-GCST90018769	rs12740374	T	G	0.0718384	Medication use (HMG CoA reductase inhibitors)	CELSR2							
1	109817590	-0.00556256	0.000500477	1.07845e-28	337159	ukb-a-176	rs12740374	T	G	0.221518	Treatment/medication code: atorvastatin	CELSR2	783	0	5.6225312612627e-24	0	0.00738085134316532	0.992619148656938	rs12740374
1	109817590	-0.00556256	0.000500477	1.07845e-28	337159	ukb-a-176	rs12740374	T	G	0.221518	Treatment/medication code: atorvastatin	CELSR2	458	0	6.24966508991275e-37	0	0.00289272031081271	0.997107279689261	rs12740374
1	109817590	0.025875	0.0023314	1.28914e-28	344104	ukb-d-30700_irnt	rs12740374	T	G	0.22181	Creatinine	CELSR2							
1	109817590	0.0229829	0.00208094	2.33077e-28	389678	ebi-a-GCST90014001	rs12740374	T	G		Creatinine levels (UKB data field 30700)	CELSR2							
1	109817590	-0.0522463	0.00487333	2.90001e-27		met-d-LA	rs12740374	T	G	0.221071	Linoleic acid	CELSR2	778	0	3.88092571614628e-23	0	0.0131129916312115	0.986887008368888	rs12740374
1	109817590	-0.0524547	0.00487511	5.30029e-27	115006	ebi-a-GCST90092880	rs12740374	T	G	0.221084	Linoleic acid levels	CELSR2							
1	109817590	0.029168	0.0027941	1.65463e-25	342439	ukb-d-30770_irnt	rs12740374	T	G	0.22182	IGF-1	CELSR2							
1	109817590	0.16293	0.015847	8.59211e-25	342439	ukb-d-30770_raw	rs12740374	T	G	0.22182	IGF-1	CELSR2							
1	109817590	-0.0110815	0.00109551	1.99986e-24	477807	ebi-a-GCST90029019	rs12740374	T	G	0.221282	Cardiovascular disease	CELSR2							
1	109817590	-0.0108442	0.00107875	2.70023e-24	484598	ebi-a-GCST90038595	rs12740374	T	G	0.221701	Cardiovascular disease	CELSR2							
1	109817590	-0.0033	3e-04	4.05789e-24	165726	ebi-a-GCST90103633	rs12740374	T	G	0.2157	Estimated glomerular filtration rate (creatinine)	CELSR2							
1	109817590	-0.0033	3e-04	5.27351e-24	1004040	ebi-a-GCST90103634	rs12740374	T	G	0.2207	Estimated glomerular filtration rate (creatinine)	CELSR2							
1	109817590	0.145115	0.0145498	1.98884e-23	25923	eqtl-a-ENSG00000168765	rs12740374	T	G	0.210449	ENSG00000168765	CELSR2	613	0	1.48310127362134e-152	0	1	3.76493842734146e-130	rs629301
1	109817590	-0.2979	0.0299	2.0893e-23	3301	prot-a-326	rs12740374	T	G	0.22252	Carbonic anhydrase-related protein 10	CELSR2	653	0	9.83660950414247e-20	0	0.0039450596333323	0.996054940366662	rs12740374
1	109817590	-0.512236	0.048708	3.48337e-23	1323	ebi-a-GCST90010219	rs12740374	T	G	0.201	Granulins levels	CELSR2							
1	109817590	0.34102	0.0348026	1.14051e-22	400	ebi-a-GCST90085768	rs12740374	T	G		Progranulin plasma levels	CELSR2							
1	109817590	0.141483	0.0145523	2.42493e-22	31212	eqtl-a-ENSG00000134202	rs12740374	T	G	0.210449	ENSG00000134202	CELSR2	613	0	3.25869655431791e-114	0	1	7.08159729278644e-96	rs12740374
1	109817590	-0.069	0.0072	5.78762e-22	153639	ebi-a-GCST90018982	rs12740374	T	G	0.140867	Medication use (antithrombotic agents)	CELSR2							
1	109817590	-0.0231675	0.00257124	4.10015e-20	400938	ebi-a-GCST90025992	rs12740374	T	G	0.221096	Serum albumin levels	CELSR2							
1	109817590	-0.0436516	0.00480342	1.69981e-19		met-d-DHA	rs12740374	T	G	0.221071	Docosahexaenoic acid	CELSR2	778	0	3.46476495215024e-16	0	0.00674066225494217	0.993259337745046	rs12740374
1	109817590	-0.0422566	0.00471867	3.40017e-19	115006	ebi-a-GCST90092816	rs12740374	T	G	0.221084	Docosahexaenoic acid levels	CELSR2							
1	109817590	0.0215461	0.0024352	8.931e-19	496946	ebi-a-GCST90000618	rs12740374	T	G	0.223491	Serum 25-Hydroxyvitamin D levels	CELSR2							
1	109817590	-0.2635	0.03	1.51356e-18	3301	prot-a-1112	rs12740374	T	G	0.22252	Four-jointed box protein 1	CELSR2	653	0	3.99432345966907e-15	0	0.00563520500924543	0.994364794990764	rs12740374
1	109817590	-0.0707	0.0082	9.78814e-18	112010	ebi-a-GCST90018995	rs12740374	T	G	0.128745	Medication use (salicylic acid and derivatives)	CELSR2							
1	109817590	0.0198925	0.00235246	2.76567e-17	417580	ebi-a-GCST90000615	rs12740374	T	G	0.223623	Serum 25-Hydroxyvitamin D levels	CELSR2							
1	109817590	-0.00515987	0.000610514	2.90001e-17	445693	ukb-b-20300	rs12740374	T	G	0.221189	Treatment speciality of consultant (recoded): Cardiology	CELSR2	505	0	9.97078186333093e-13	0	0.00572333354904469	0.994276666449951	rs12740374
1	109817590	0.0207723	0.0025314	3.59998e-17	418691	ebi-a-GCST90025967	rs12740374	T	G	0.223334	Vitamin D levels	CELSR2							
1	109817590	0.01982	0.0023529	3.64922e-17	417580	ebi-a-GCST90000616	rs12740374	T	G	0.223598	Serum 25-Hydroxyvitamin D levels	CELSR2							
1	109817590	-0.00520624	0.000618769	3.69999e-17	484598	ebi-a-GCST90038605	rs12740374	T	G	0.221701	Cardiac problem	CELSR2							
1	109817590	0.0196043	0.0023575	9.12011e-17	417580	ebi-a-GCST90000617	rs12740374	T	G	0.223623	Serum 25-Hydroxyvitamin D levels	CELSR2							
1	109817590	-0.0203014	0.00253015	1.59993e-16	400482	ebi-a-GCST90025995	rs12740374	T	G	0.221124	Serum total protein level	CELSR2							
1	109817590	0.0186	0.0023	1.71317e-16	450243	ebi-a-GCST90000025	rs12740374	T	G	0.2214	Appendicular lean mass	CELSR2							
1	109817590	0.0195356	0.00238927	2.92483e-16	417580	ebi-a-GCST90000614	rs12740374	T	G	0.223598	Serum 25-Hydroxyvitamin D levels	CELSR2							
1	109817590	0.018837	0.002324	5.25654e-16		ieu-b-4812	rs12740374	T	G	0.223883	25 hydroxyvitamin D level	CELSR2							
1	109817590	-0.0212923	0.00270043	3.15065e-15	357968	ebi-a-GCST90013990	rs12740374	T	G		Albumin levels (UKB data field 30600)	CELSR2							
1	109817590	-0.00149391	0.000190634	4.60045e-15	462933	ukb-b-6474	rs12740374	T	G	0.221164	Treatment/medication code: ezetimibe	CELSR2	783	0	1.65616154754272e-07	0	0.00447399524405224	0.995525839139894	rs12740374
1	109817590	-0.00149391	0.000190634	4.60045e-15	462933	ukb-b-6474	rs12740374	T	G	0.221164	Treatment/medication code: ezetimibe	CELSR2	305	0	5.29423868367924e-10	0	0.00307017948765197	0.996929819982979	rs12740374
1	109817590	0.2326	0.0301	1.02329e-14	3301	prot-a-2033	rs12740374	T	G	0.22252	Neogenin	CELSR2	653	0	1.60093610449579e-11	0	0.00476336378843563	0.995236636195641	rs12740374
1	109817590	0.0190608	0.00246967	1.20005e-14	408112	ebi-a-GCST90002397	rs12740374	T	G	0.221719	Mean spheric corpuscular volume	CELSR2							
1	109817590	-0.2313	0.0301	1.41254e-14	3301	prot-a-1332	rs12740374	T	G	0.22252	Hemojuvelin	CELSR2	653	0	2.48568596007059e-11	0	0.0024893449367109	0.997510655038417	rs12740374
1	109817590	-0.00644191	0.000843336	2.19989e-14	462933	ukb-b-8755	rs12740374	T	G	0.221164	Treatment/medication code: aspirin	CELSR2	783	0	5.42670804808386e-06	0	0.00544786231986705	0.994546710972152	rs12740374
1	109817590	-0.00644191	0.000843336	2.19989e-14	462933	ukb-b-8755	rs12740374	T	G	0.221164	Treatment/medication code: aspirin	CELSR2	598	0	5.23181718868352e-10	0	0.00405710505465964	0.995942894422138	rs12740374
1	109817590	0.34322	0.04511	2.78035e-14	344104	ukb-d-30700_raw	rs12740374	T	G	0.22181	Creatinine	CELSR2							
1	109817590	0.0174772	0.00233778	3.69999e-14	436939	ebi-a-GCST90025959	rs12740374	T	G	0.221322	C-reactive protein levels	CELSR2							
1	109817590	-0.00653194	0.000868337	5.40008e-14	457547	ukb-b-7137	rs12740374	T	G	0.221124	Medication for pain relief, constipation, heartburn: Aspirin	CELSR2	604	0	1.17609052141791e-09	0	0.00809247286041291	0.991907525963462	rs12740374
1	109817590	-0.00279703	0.000374557	8.19974e-14	461880	ukb-b-11590	rs12740374	T	G	0.221186	Vascular/heart problems diagnosed by doctor: Heart attack	CELSR2	783	0	0.000296886425733392	0	0.0107123799383482	0.988990733635887	rs12740374
1	109817590	-0.00279703	0.000374557	8.19974e-14	461880	ukb-b-11590	rs12740374	T	G	0.221186	Vascular/heart problems diagnosed by doctor: Heart attack	CELSR2	439	0	3.98958407659579e-09	0	0.00628649773770776	0.993713498272703	rs12740374
1	109817590	0.0141991	0.00185161	1.39991e-13	673878	ebi-a-GCST90029008	rs12740374	T	G	0.2213	Height	CELSR2							
1	109817590	0.0140228	0.0018514	2.39994e-13	458235	ebi-a-GCST90025949	rs12740374	T	G	0.221298	Height	CELSR2							
1	109817590	-0.00406951	0.000560099	3.69999e-13	461416	ukb-b-16376	rs12740374	T	G	0.22115	Main speciality of consultant (recoded): Cardiology	CELSR2	493	0	1.17765067545113e-08	0	0.0186558491534968	0.981344139070057	rs12740374
1	109817590	0.0174386	0.0025137	4.60045e-13	372420	ebi-a-GCST90025983	rs12740374	T	G	0.222209	Direct bilirubin levels	CELSR2							
1	109817590	-0.0170824	0.00234479	5.79963e-13	437651	ebi-a-GCST90025966	rs12740374	T	G	0.221332	Gamma glutamyl transferase levels	CELSR2							
1	109817590	-0.00891767	0.00124901	9.30037e-13	407557	ukb-b-18408	rs12740374	T	G	0.221087	Illnesses of father: Heart disease	CELSR2	783	0	7.74125332526745e-07	0	0.0437508571210097	0.956248368753605	rs12740374
1	109817590	-0.00891767	0.00124901	9.30037e-13	407557	ukb-b-18408	rs12740374	T	G	0.221087	Illnesses of father: Heart disease	CELSR2	638	0	1.00824417120655e-08	0	0.118067998357234	0.881931991560421	rs12740374
1	109817590	0.0191632	0.00269676	1.19454e-12	373045	ebi-a-GCST90014016	rs12740374	T	G		Vitamin D levels (UKB data field 30890)	CELSR2							
1	109817590	-0.020958	0.0029634	1.52581e-12	315268	ukb-d-30600_irnt	rs12740374	T	G	0.22158	Albumin	CELSR2							
1	109817590	-0.054646	0.0077426	1.69434e-12	315268	ukb-d-30600_raw	rs12740374	T	G	0.22158	Albumin	CELSR2							
1	109817590	-0.00158352	0.000225003	1.95704e-12	337159	ukb-a-191	rs12740374	T	G	0.221518	Treatment/medication code: ezetimibe	CELSR2	783	0	1.65616154754272e-07	0	0.00447399524405224	0.995525839139894	rs12740374
1	109817590	-0.00158352	0.000225003	1.95704e-12	337159	ukb-a-191	rs12740374	T	G	0.221518	Treatment/medication code: ezetimibe	CELSR2	305	0	5.29423868367924e-10	0	0.00307017948765197	0.996929819982979	rs12740374
1	109817590	-0.102391	0.0145755	2.14092e-12	23156	eqtl-a-ENSG00000134184	rs12740374	T	G	0.210449	ENSG00000134184	CELSR2	609	0	4.18476192346024e-92	0	1	1.24581810361092e-83	rs12740374
1	109817590	-0.0139846	0.00199246	2.19989e-12	462933	ukb-b-3656	rs12740374	T	G	0.221164	Number of treatments/medications taken	CELSR2							
1	109817590	-0.0167277	0.00257399	3.19963e-12	400792	ebi-a-GCST90025990	rs12740374	T	G	0.221135	Calcium levels	CELSR2							
1	109817590	0.0107378	0.00156107	6.00067e-12	461950	ukb-b-10787	rs12740374	T	G	0.221181	Standing height	CELSR2							
1	109817590	-0.076	0.0112	1.06807e-11	21758	ebi-a-GCST90012000	rs12740374	T	G	0.223	E-selectin levels	CELSR2							
1	109817590	-0.00939275	0.00139803	1.84035e-11	190094	ukb-d-2654_2	rs12740374	T	G	0.219857	Non-butter spread type details: Flora Pro-Active or Benecol	CELSR2	861	0	2.2512622307386e-07	0	0.00777822977090318	0.992221545102846	rs12740374
1	109817590	-0.0596	0.009	3.49784e-11	224024	ebi-a-GCST90018986	rs12740374	T	G	0.154134	Medication use (beta blocking agents)	CELSR2							
1	109817590	0.0963618	0.0145784	3.84858e-11	30998	eqtl-a-ENSG00000031698	rs12740374	T	G	0.210449	ENSG00000031698	CELSR2	613	0	1.59474841794591e-37	0	1	2.50803897018142e-30	rs12740374
1	109817590	0.40669	0.061651	4.21211e-11	329247	ukb-d-30890_raw	rs12740374	T	G	0.22378	Vitamin D	CELSR2							
1	109817590	-0.0181	0.0027	4.23156e-11	315268	ebi-a-GCST90018945	rs12740374	T	G	0.180278	Serum albumin levels	CELSR2							
1	109817590	-0.0303175	0.0046727	4.30031e-11		met-d-Cholines	rs12740374	T	G	0.221071	Total cholines	CELSR2	778	0	2.36457191284479e-07	0	0.0085152360508725	0.991484527492021	rs12740374
1	109817590	-0.080427	0.0122	4.3401e-11	314921	ukb-d-30860_raw	rs12740374	T	G	0.22162	Total protein	CELSR2							
1	109817590	-0.019923	0.0030246	4.49469e-11	314921	ukb-d-30860_irnt	rs12740374	T	G	0.22162	Total protein	CELSR2							
1	109817590	0.019272	0.0029381	5.42126e-11	329247	ukb-d-30890_irnt	rs12740374	T	G	0.22378	Vitamin D	CELSR2							
1	109817590	-0.00128416	0.000196453	6.29941e-11	462933	ukb-b-13664	rs12740374	T	G	0.221164	Treatment/medication code: rosuvastatin	CELSR2	307	0	5.91001292366042e-06	0	0.00247916228259534	0.997514927704548	rs12740374
1	109817590	-0.00949534	0.0014587	7.5544e-11	292053	ukb-a-201	rs12740374	T	G	0.221518	Illnesses of father: Heart disease	CELSR2	783	0	7.74125332526745e-07	0	0.0437508571210097	0.956248368753605	rs12740374
1	109817590	-0.00949534	0.0014587	7.5544e-11	292053	ukb-a-201	rs12740374	T	G	0.221518	Illnesses of father: Heart disease	CELSR2	638	0	1.00824417120655e-08	0	0.118067998357234	0.881931991560421	rs12740374
1	109817590	-0.0181	0.0028	8.51138e-11	314921	ebi-a-GCST90018976	rs12740374	T	G	0.17711	Serum total protein level	CELSR2							
1	109817590	0.00955988	0.00147791	9.8992e-11	454463	ukb-b-9685	rs12740374	T	G	0.22129	Trunk predicted mass	CELSR2							
1	109817590	0.00955295	0.00148265	1.2e-10	454508	ukb-b-17409	rs12740374	T	G	0.221286	Trunk fat-free mass	CELSR2							
1	109817590	-0.0302647	0.00472796	1.7e-10		met-d-Unsaturation	rs12740374	T	G	0.221071	Degree of unsaturation	CELSR2	778	0	4.10441146742904e-07	0	0.00510886186308004	0.994890727695849	rs12740374
1	109817590	0.0156	0.0024	1.72302e-10	575531	ebi-a-GCST90029070	rs12740374	T	G		C-reactive protein levels	CELSR2							
1	109817590	-0.0296544	0.00466366	2e-10	115006	ebi-a-GCST90092812	rs12740374	T	G	0.221084	Total cholines levels	CELSR2							
1	109817590	-0.0149617	0.00235617	2.15293e-10	389672	ebi-a-GCST90014004	rs12740374	T	G		Gamma glutamyltransferase levels (UKB data field 30730)	CELSR2							
1	109817590	-0.0834	0.0131	2.23398e-10		finn-b-E4_METABOLIA	rs12740374	T	G	0.2145	Metabolic disorders	CELSR2	751	0	2.67338347481829e-07	0	0.00589227202118634	0.994107460640545	rs12740374
1	109817590	0.0163582	0.00258602	2.52209e-10	389057	ebi-a-GCST90014002	rs12740374	T	G		C reactive protein levels (UKB data field 30710)	CELSR2							
1	109817590	-0.00622151	0.000989098	3.17695e-10	337159	ukb-a-132	rs12740374	T	G	0.221518	Treatment/medication code: aspirin	CELSR2	783	0	5.42670804808386e-06	0	0.00544786231986705	0.994546710972152	rs12740374
1	109817590	-0.00622151	0.000989098	3.17695e-10	337159	ukb-a-132	rs12740374	T	G	0.221518	Treatment/medication code: aspirin	CELSR2	598	0	5.23181718868352e-10	0	0.00405710505465964	0.995942894422138	rs12740374
1	109817590	0.00931472	0.00148816	3.89996e-10	454850	ukb-b-13354	rs12740374	T	G	0.221296	Whole body fat-free mass	CELSR2							
1	109817590	-0.0294446	0.00471188	4.09996e-10	115006	ebi-a-GCST90092994	rs12740374	T	G	0.221084	Degree of unsaturation	CELSR2	778	0	4.10441146742904e-07	0	0.00510886186308004	0.994890727695849	rs12740374
1	109817590	-0.041	0.0066	4.54402e-10	237530	ebi-a-GCST90018988	rs12740374	T	G	0.158064	Medication use (agents acting on the renin-angiotensin system)	CELSR2							
1	109817590	0.0155596	0.00249768	4.67617e-10	332739	ebi-a-GCST90013997	rs12740374	T	G		Direct bilirubin levels (UKB data field 30660)	CELSR2							
1	109817590	0.0141008	0.00226583	4.86911e-10	389834	ebi-a-GCST90014003	rs12740374	T	G		Cystatin C levels (UKB data field 30720)	CELSR2							
1	109817590	-0.00131604	0.000212108	5.49997e-10	462933	ukb-b-18062	rs12740374	T	G	0.221164	Treatment/medication code: lipitor 10mg tablet	CELSR2	320	0	4.30723507494941e-05	0	0.00415621592773134	0.995800711721489	rs12740374
1	109817590	0.00915855	0.00149063	8e-10	454888	ukb-b-14540	rs12740374	T	G	0.221299	Whole body water mass	CELSR2							
1	109817590	0.017632	0.002875	8.65207e-10	343524	ukb-d-30710_irnt	rs12740374	T	G	0.22177	C-reactive protein	CELSR2							
1	109817590	0.0142466	0.00231036	9.29994e-10	437846	ebi-a-GCST90025945	rs12740374	T	G	0.221343	Cystatin C levels	CELSR2							
1	109817590	-0.00621654	0.00101623	9.53125e-10	333581	ukb-a-452	rs12740374	T	G	0.221518	Medication for pain relief  constipation  heartburn: Aspirin	CELSR2	783	0	1.51299957307665e-05	0	0.00738258394611124	0.992602286058133	rs12740374
1	109817590	0.0141936	0.00232411	1.40001e-09	535537	ebi-a-GCST90028997	rs12740374	T	G	0.221211	Mean sphered cell volume	CELSR2							
1	109817590	0.00889679	0.0014519	1.5e-09	534045	ebi-a-GCST90029025	rs12740374	T	G	0.221417	Basal metabolic rate	CELSR2							
1	109817590	-0.0156693	0.00261358	1.6e-09	415311	ebi-a-GCST006701	rs12740374	T	G	0.221783	Parental longevity (father's attained age)	CELSR2							
1	109817590	0.0133548	0.00223896	1.7e-09	437736	ebi-a-GCST90025976	rs12740374	T	G	0.221213	Mean sphered cell volume	CELSR2							
1	109817590	0.0877895	0.0145822	1.74201e-09	31212	eqtl-a-ENSG00000181754	rs12740374	T	G	0.210449	ENSG00000181754	CELSR2	613	0	5.40625108901849e-102	0	1	2.78999071033731e-96	rs12740374
1	109817590	-0.0140787	0.00246436	2.59998e-09	437724	ebi-a-GCST90025979	rs12740374	T	G	0.221325	Alanine aminotransferase levels	CELSR2							
1	109817590	-0.0574	0.0097	2.97303e-09	977323	ebi-a-GCST009541	rs12740374	T	G		Heart failure	CELSR2							
1	109817590	-0.0144405	0.00240166	3.2e-09	397043	ebi-a-GCST90025958	rs12740374	T	G	0.221106	Sex hormone-binding globulin levels	CELSR2							
1	109817590	0.00876812	0.0014816	3.29997e-09	454753	ukb-b-19520	rs12740374	T	G	0.221296	Arm fat-free mass (right)	CELSR2							
1	109817590	-0.087897	0.014933	4.58997e-09	13474	met-c-935	rs12740374	T	G	0.213401	Sphingomyelins	CELSR2	613	0	3.3911308356898e-06	0	0.00485699198041103	0.995139616888849	rs12740374
1	109817590	-0.087897	0.014933	4.58997e-09	13474	met-c-935	rs12740374	T	G	0.213401	Sphingomyelins	CELSR2	778	0	4.89750376946767e-59	0	0.000662397052784127	0.999337602947301	rs12740374
1	109817590	0.0168713	0.00287987	4.67875e-09	344729	ukb-d-30270_irnt	rs12740374	T	G	0.221741	Mean sphered cell volume	CELSR2							
1	109817590	-0.00606295	0.00103692	5.00795e-09	361194	ukb-d-IX_CIRCULATORY	rs12740374	T	G	0.221809	Diseases of the circulatory system	CELSR2	861	0	7.32255017743553e-05	0	0.00817772501309352	0.991749049485082	rs12740374
1	109817590	-0.00581546	0.00100056	8e-09	368929	ebi-a-GCST90012110	rs12740374	T	G	0.221727	Sex hormone-binding globulin levels adjusted for BMI	CELSR2							
1	109817590	0.0102	0.0018	8.15098e-09	360388	ebi-a-GCST90018959	rs12740374	T	G	0.174675	Height	CELSR2							
1	109817590	-0.00252512	0.000438611	8.56604e-09	336683	ukb-a-434	rs12740374	T	G	0.221518	Vascular/heart problems diagnosed by doctor: Heart attack	CELSR2	783	0	0.000296886425733392	0	0.0107123799383482	0.988990733635887	rs12740374
1	109817590	-0.00252512	0.000438611	8.56604e-09	336683	ukb-a-434	rs12740374	T	G	0.221518	Vascular/heart problems diagnosed by doctor: Heart attack	CELSR2	439	0	3.98958407659579e-09	0	0.00628649773770776	0.993713498272703	rs12740374
1	109817590	0.0130721	0.00220134	1.09999e-08	426824	ebi-a-GCST006979	rs12740374	T	G	0.22183	Heel bone mineral density	CELSR2							
1	109817590	0.014951	0.0026195	1.14609e-08	344264	ukb-d-30720_irnt	rs12740374	T	G	0.22179	Cystatin C	CELSR2							
1	109817590	0.00839294	0.00147669	1.29999e-08	454746	ukb-b-16698	rs12740374	T	G	0.221292	Arm predicted mass (right)	CELSR2							
1	109817590	-0.00485928	0.000861872	1.7e-08	363542	ukb-b-14371	rs12740374	T	G	0.220962	Illnesses of siblings: Heart disease	CELSR2	783	0	0.515508741852716	0	0.00476202994770989	0.479729228199632	rs12740374
1	109817590	-0.00485928	0.000861872	1.7e-08	363542	ukb-b-14371	rs12740374	T	G	0.220962	Illnesses of siblings: Heart disease	CELSR2	553	0	0.000290212216775526	0	0.00238801610455843	0.997321771678577	rs12740374
1	109817590	0.0154	0.0028	2.14699e-08	353466	ebi-a-GCST90018950	rs12740374	T	G	0.193363	C-reactive protein	CELSR2							
1	109817590	0.00871853	0.00156011	2.30001e-08	454835	ukb-b-12828	rs12740374	T	G	0.221296	Leg fat-free mass (right)	CELSR2							
1	109817590	0.0173226	0.00303339	2.30001e-08	244730	ebi-a-GCST90000027	rs12740374	T	G	0.221072	Appendicular lean mass	CELSR2							
1	109817590	0.00873667	0.00156538	2.39999e-08	454874	ukb-b-16446	rs12740374	T	G	0.221299	Basal metabolic rate	CELSR2							
1	109817590	0.0200929	0.00336423	2.39999e-08	205513	ebi-a-GCST90000026	rs12740374	T	G	0.221743	Appendicular lean mass	CELSR2							
1	109817590	-0.0151183	0.00272744	2.97269e-08	357831	ebi-a-GCST90013999	rs12740374	T	G		Calcium levels (UKB data field 30680)	CELSR2							
1	109817590	0.00826694	0.00150463	3.89996e-08	454655	ukb-b-9093	rs12740374	T	G	0.221299	Arm predicted mass (left)	CELSR2							
1	109817590	0.00848754	0.00155005	4.39997e-08	454834	ukb-b-14310	rs12740374	T	G	0.221296	Leg predicted mass (right)	CELSR2							
1	109817590	0.019	0.0036	5.60003e-08	252881	ieu-a-89	rs12740374	T	G	0.302	Height	CELSR2							
1	109817590	0.0133011	0.0024808	8.24803e-08	365403	ebi-a-GCST90014022	rs12740374	T	G		Bone mineral density	CELSR2							
1	109817590	0.00804522	0.00151066	1e-07	454672	ukb-b-19925	rs12740374	T	G	0.221296	Arm fat-free mass (left)	CELSR2							
1	109817590	-0.0143145	0.00269005	1e-07	389166	ebi-a-GCST006697	rs12740374	T	G	0.221677	Parental longevity (combined parental attained age, Martingale residuals)	CELSR2							
1	109817590	-0.0131	0.0025	1.28e-07	344104	ebi-a-GCST90018954	rs12740374	T	G	0.179894	Gamma glutamyl transpeptidase	CELSR2							
1	109817590	-0.1588	0.0302	1.44544e-07	3301	prot-a-2760	rs12740374	T	G	0.22252	Sodium-coupled monocarboxylate transporter 1	CELSR2	653	0	7.47044665205621e-05	0	0.0142745169387843	0.985650778594663	rs12740374
1	109817590	-0.0016442	0.000312899	1.5e-07	463010	ukb-b-9592	rs12740374	T	G	0.221167	Operative procedures - main OPCS: K63.3 Angiocardiography of left side of heart NEC	CELSR2	409	0	0.00644020175452784	0	0.0114270025930713	0.982132795652405	rs12740374
1	109817590	-0.07	0.0134	1.61102e-07		finn-b-I9_CVD_HARD	rs12740374	T	G	0.2145	Hard cardiovascular diseases	CELSR2	751	0	0.000185024698201593	0	0.0075271881807652	0.99228778712096	rs12740374
1	109817590	0.0096063	0.00183496	1.64945e-07	330995	ukb-a-293	rs12740374	T	G	0.221518	Trunk predicted mass	CELSR2							
1	109817590	0.00963763	0.00184095	1.64953e-07	331030	ukb-a-292	rs12740374	T	G	0.221518	Trunk fat-free mass	CELSR2							
1	109817590	-0.0129	0.0025	2.15998e-07	344136	ebi-a-GCST90018943	rs12740374	T	G	0.176084	Alanine aminotransferase levels	CELSR2							
1	109817590	0.0080335	0.00155079	2.19999e-07	454799	ukb-b-17271	rs12740374	T	G	0.221295	Leg predicted mass (left)	CELSR2							
1	109817590	-0.0130497	0.00254982	2.5e-07	446811	ebi-a-GCST90029026	rs12740374	T	G	0.221029	Lung function (FEV1/FVC)	CELSR2							
1	109817590	-0.0842	0.0163	2.625e-07	242659	ebi-a-GCST90018983	rs12740374	T	G	0.15717	Medication use (vasodilators used in cardiac diseases)	CELSR2							
1	109817590	-0.0126473	0.00246394	2.852e-07	389733	ebi-a-GCST90013992	rs12740374	T	G		Alanine aminotransferase levels (UKB data field 30620)	CELSR2							
1	109817590	-0.0120148	0.00234401	2.96545e-07	337159	ukb-a-24	rs12740374	T	G	0.221518	Number of treatments/medications taken	CELSR2							
1	109817590	-0.0128132	0.00254371	3.40001e-07	371898	ebi-a-GCST90025978	rs12740374	T	G	0.221026	Lung function (FEV1/FVC)	CELSR2							
1	109817590	-0.0015302	0.000300317	3.50002e-07	462933	ukb-b-17378	rs12740374	T	G	0.221164	Treatment/medication code: bisoprolol	CELSR2	407	0	0.0139123912296685	0	0.0096081970576521	0.97647941171274	rs12740374
1	109817590	0.00794349	0.00156103	3.59998e-07	454805	ukb-b-16099	rs12740374	T	G	0.221293	Leg fat-free mass (left)	CELSR2							
1	109817590	0.0152	0.003	3.67799e-07	350741	ebi-a-GCST90095038	rs12740374	T	G	0.2784	Height	CELSR2							
1	109817590	-0.076545	0.014954	3.73001e-07	13525	met-c-893	rs12740374	T	G	0.21352	18:2, linoleic acid (LA)	CELSR2	615	0	0.0002234798613195	0	0.00630978253845954	0.9934667376002	rs12740374
1	109817590	-0.4254	0.0842	4.35702e-07	76511	ieu-b-4832	rs12740374	T	G		Estimated glomerular filtration rate	CELSR2							
1	109817590	0.0136	0.0027	4.90501e-07	349856	ebi-a-GCST90018962	rs12740374	T	G	0.189788	Lymphocyte count	CELSR2							
1	109817590	-0.00229583	0.000466561	5e-07	437267	ebi-a-GCST90013405	rs12740374	T	G	0.221304	Liver enzyme levels (alanine transaminase)	CELSR2							
1	109817590	0.0122674	0.00235843	5.1e-07	509277	ebi-a-GCST90028994	rs12740374	T	G	0.221254	White blood cell count (lymphocyte)	CELSR2							
1	109817590	0.010341	0.00207691	6.39411e-07	336474	ukb-a-389	rs12740374	T	G	0.221518	Standing height	CELSR2							
1	109817590	0.011468	0.002304	6.58006e-07	486823	ebi-a-GCST90002322	rs12740374	T	G	0.221645	Mean corpuscular hemoglobin	CELSR2							
1	109817590	-0.00586073	0.00111619	6.69993e-07	370125	ebi-a-GCST90012111	rs12740374	T	G	0.221712	Sex hormone-binding globulin levels	CELSR2							
1	109817590	0.0131	0.0026	7.10395e-07	350473	ebi-a-GCST90018966	rs12740374	T	G	0.181226	Mean corpuscular volume	CELSR2							
1	109817590	0.0126329	0.00255837	7.89878e-07	395949	ebi-a-GCST90013982	rs12740374	T	G		Lymphocyte count (UKB data field 30120)	CELSR2							
1	109817590	0.00931389	0.00189094	8.41298e-07	810865	ebi-a-GCST90000059	rs12740374	T	G	0.2221	Diastolic blood pressure	CELSR2							
1	109817590	-0.0101041	0.00205388	8.70001e-07	462933	ukb-b-4063	rs12740374	T	G	0.221164	Number of self-reported non-cancer illnesses	CELSR2							
1	109817590	0.010729	0.002181	8.85992e-07	544127	ebi-a-GCST90002334	rs12740374	T	G	0.22107	Mean corpuscular volume	CELSR2							
1	109817590	0.0109876	0.002222	9.09997e-07	445855	ebi-a-GCST90025982	rs12740374	T	G	0.221368	Heel bone mineral density T score	CELSR2							
1	109817590	0.073457	0.014923	9.43996e-07	13530	met-c-847	rs12740374	T	G	0.213444	Average number of methylene groups per double bond	CELSR2	615	0	0.000652872641290933	0	0.016640348885399	0.982706778473263	rs12740374
2	187532373	0.293047	0.0199929	1.20809e-48	31568	eqtl-a-ENSG00000138448	rs2595391	G	T	0.0966293	ENSG00000138448	ITGAV	13	0	0.984876254492016	0	0.000230881912857293	0.0148928635949086	rs10455872
2	187532373	-0.1126	0.0205	3.71903e-08	59957	ebi-a-GCST004131	rs2595391	G	T		Inflammatory bowel disease	ITGAV							
2	187532373	0.0183273	0.00358963	8.40001e-08	371898	ebi-a-GCST90025978	rs2595391	G	T	0.099978	Lung function (FEV1/FVC)	ITGAV							
2	187532373	0.0181079	0.00363279	2.1e-07	400159	ebi-a-GCST90025948	rs2595391	G	T	0.0999927	Serum phosphate levels	ITGAV							
2	187532373	0.0185196	0.00357125	2.15144e-07	357302	ebi-a-GCST90014010	rs2595391	G	T		Phosphate levels (UKB data field 30810)	ITGAV							
2	187532373	0.0166368	0.00339937	2.80001e-07	446811	ebi-a-GCST90029026	rs2595391	G	T	0.1093	Lung function (FEV1/FVC)	ITGAV							
2	187532373	-0.0139911	0.00316802	5.89997e-07	513859	ebi-a-GCST90028992	rs2595391	G	T	0.109442	White blood cell count (eosinophil)	ITGAV							
2	187532373	-0.062755	0.012766	8.89201e-07		ubm-b-1695	rs2595391	G	T	0.10809	IDP_dMRI_TBSS_L1_Uncinate_fasciculus_L	ITGAV	1526	0	0.908970676550557	0	0.0810093817258668	0.0100199417234345	rs56393506
1	55505647	0.046744	0.007316	0		ieu-b-4808	rs11591147	T	G	0.01799	25 hydroxyvitamin D level	PCSK9							
1	55505647	-0.6142	0.0245	6.62217e-139		finn-b-RX_STATIN	rs11591147	T	G	0.03609	Statin medication	PCSK9	1053	0	4.65315149683007e-24	0	1	3.35268870605659e-25	rs73015965
1	55505647	-0.3623	0.0215	9.42758e-64	290385	ebi-a-GCST90018989	rs11591147	T	G	0.017203	Medication use (HMG CoA reductase inhibitors)	PCSK9							
1	55505647	-0.228354	0.014707	1.29987e-56		met-d-Sphingomyelins	rs11591147	T	G	0.017465	Sphingomyelins	PCSK9	875	1.66952850292051e-308	0.880519962862385	1.6688412108102e-308	0.0435378421023322	0.0759421950352274	rs73027818
1	55505647	-0.228354	0.014707	1.29987e-56		met-d-Sphingomyelins	rs11591147	T	G	0.017465	Sphingomyelins	PCSK9	1264	0	5.13809802279083e-05	0	0.999940170732386	8.44828737199876e-06	rs73015965
1	55505647	-0.227522	0.0146943	4.49987e-54	115006	ebi-a-GCST90092982	rs11591147	T	G	0.017464	Sphingomyelin levels	PCSK9							
1	55505647	-0.0297996	0.00249708	7.89951e-33	462933	ukb-b-11268	rs11591147	T	G	0.017452	Treatment/medication code: simvastatin	PCSK9	1073	0	1.88485326599909e-07	0	0.999999809997253	1.51743831581218e-09	rs73015965
1	55505647	-0.0297996	0.00249708	7.89951e-33	462933	ukb-b-11268	rs11591147	T	G	0.017452	Treatment/medication code: simvastatin	PCSK9	753	3.54597409458494e-244	6.25798932529629e-10	5.66631534194156e-235	0.999999999373358	8.15171718939785e-13	rs4252129
1	55505647	-0.156709	0.0154315	4.40048e-26		met-d-LA	rs11591147	T	G	0.017465	Linoleic acid	PCSK9	1264	0	1.24364125171981e-33	0	1	1.02545672563523e-34	rs73015965
1	55505647	-0.0309811	0.00293635	5.07925e-26	337159	ukb-a-121	rs11591147	T	G	0.0174556	Treatment/medication code: simvastatin	PCSK9	1073	0	1.88485326599909e-07	0	0.999999809997253	1.51743831581218e-09	rs73015965
1	55505647	-0.0309811	0.00293635	5.07925e-26	337159	ukb-a-121	rs11591147	T	G	0.0174556	Treatment/medication code: simvastatin	PCSK9	753	3.54597409458494e-244	6.25798932529629e-10	5.66631534194156e-235	0.999999999373358	8.15171718939785e-13	rs4252129
1	55505647	-0.155986	0.0154372	5.30029e-24	115006	ebi-a-GCST90092880	rs11591147	T	G	0.017464	Linoleic acid levels	PCSK9							
1	55505647	-0.368426	0.039901	3.74024e-20	13473	met-c-935	rs11591147	T	G	0.028653	Sphingomyelins	PCSK9	875	1.66952850292051e-308	0.880519962862385	1.6688412108102e-308	0.0435378421023322	0.0759421950352274	rs73027818
1	55505647	-0.368426	0.039901	3.74024e-20	13473	met-c-935	rs11591147	T	G	0.028653	Sphingomyelins	PCSK9	1264	0	5.13809802279083e-05	0	0.999940170732386	8.44828737199876e-06	rs73015965
1	55505647	-0.2602	0.0297	1.83021e-18		finn-b-E4_METABOLIA	rs11591147	T	G	0.03609	Metabolic disorders	PCSK9	1053	0	0.140017608395371	0	0.848964804909982	0.0110175866946535	rs73015965
1	55505647	-0.314397	0.039922	5.31986e-15	13525	met-c-893	rs11591147	T	G	0.028751	18:2, linoleic acid (LA)	PCSK9	875	1.66956227528807e-308	0.921644111748601	1.66882735940895e-308	0.0266954624947498	0.0516604257566565	rs73027818
1	55505647	-0.110337	0.0147962	6.09958e-15		met-d-Cholines	rs11591147	T	G	0.017465	Total cholines	PCSK9	1264	0	1.01363040013988e-06	0	0.999998951745378	3.46242067014054e-08	rs73015965
1	55505647	-0.111414	0.0152101	5.30029e-14		met-d-DHA	rs11591147	T	G	0.017465	Docosahexaenoic acid	PCSK9	1264	0	0.861028141563598	0	0.0296505038505622	0.109321354585874	rs73015965
1	55505647	-0.0119231	0.00158604	5.595e-14	337159	ukb-a-176	rs11591147	T	G	0.0174556	Treatment/medication code: atorvastatin	PCSK9	1073	0	6.2454345586162e-12	0	0.999999999993747	1.06929472999958e-14	rs73015965
1	55505647	-0.0119231	0.00158604	5.595e-14	337159	ukb-a-176	rs11591147	T	G	0.0174556	Treatment/medication code: atorvastatin	PCSK9	613	8.36353975904335e-249	2.86650120445712e-21	2.91768227623273e-228	1	1.63018342002041e-23	rs11751347
1	55505647	-0.112079	0.0149419	6.29941e-14	115006	ebi-a-GCST90092816	rs11591147	T	G	0.017464	Docosahexaenoic acid levels	PCSK9							
1	55505647	-0.109707	0.0147677	1.10002e-13	115006	ebi-a-GCST90092812	rs11591147	T	G	0.017464	Total cholines levels	PCSK9							
1	55505647	0.0519075	0.00802549	8.10028e-13	372420	ebi-a-GCST90025983	rs11591147	T	G	0.0179398	Direct bilirubin levels	PCSK9							
1	55505647	-0.0245794	0.00349628	2.70023e-12	484598	ebi-a-GCST90038595	rs11591147	T	G	0.016707	Cardiovascular disease	PCSK9							
1	55505647	-0.023651	0.00347203	8.99912e-12	477807	ebi-a-GCST90029019	rs11591147	T	G	0.017467	Cardiovascular disease	PCSK9							
1	55505647	-0.0971407	0.0149204	7.50067e-11	115006	ebi-a-GCST90092994	rs11591147	T	G	0.017464	Degree of unsaturation	PCSK9	1264	0	6.61717539258483e-29	0	1	1.22695413464281e-30	rs73015965
1	55505647	-0.260498	0.039856	8.61986e-11	13539	met-c-918	rs11591147	T	G	0.029011	Phosphatidylcholine and other cholines	PCSK9	875	1.66954489802584e-308	0.900484057819285	1.66883660987087e-308	0.0379497173342439	0.0615662248464938	rs73027818
1	55505647	-0.0948857	0.0149712	1.2e-10		met-d-Unsaturation	rs11591147	T	G	0.017465	Degree of unsaturation	PCSK9	1264	0	6.61717539258483e-29	0	1	1.22695413464281e-30	rs73015965
1	55505647	0.046744	0.007316	1.66663e-10		ieu-b-4812	rs11591147	T	G	0.01799	25 hydroxyvitamin D level	PCSK9							
1	55505647	0.0466153	0.00736394	2.44833e-10	417580	ebi-a-GCST90000615	rs11591147	T	G	0.018031	Serum 25-Hydroxyvitamin D levels	PCSK9							
1	55505647	-0.207321	0.0329668	3.2e-10	13814	ebi-a-GCST90060507	rs11591147	T	G	0.0181376	Sphingomyelin_42:2_[M+OAc]1- levels	PCSK9							
1	55505647	-0.252215	0.039851	3.22003e-10	13517	met-c-937	rs11591147	T	G	0.028809	Total phosphoglycerides	PCSK9	875	1.66955345600463e-308	0.910904991238711	1.66883556885042e-308	0.0366912434668832	0.0524037652943975	rs73027818
1	55505647	0.0461643	0.00736307	3.61735e-10	417580	ebi-a-GCST90000616	rs11591147	T	G	0.018041	Serum 25-Hydroxyvitamin D levels	PCSK9							
1	55505647	0.0482586	0.00785293	7.98123e-10	332739	ebi-a-GCST90013997	rs11591147	T	G		Direct bilirubin levels (UKB data field 30660)	PCSK9							
1	55505647	-0.0243457	0.00396351	8.10009e-10	407557	ukb-b-18408	rs11591147	T	G	0.017431	Illnesses of father: Heart disease	PCSK9	1073	0	8.60951661940868e-26	0	1	6.77757608141751e-28	rs73015965
1	55505647	-0.0243457	0.00396351	8.10009e-10	407557	ukb-b-18408	rs11591147	T	G	0.017431	Illnesses of father: Heart disease	PCSK9	865	0	1.32472276006407e-42	0	1	2.92046693541649e-44	rs73015965
1	55505647	-0.0842838	0.0147398	1.2e-09		met-d-Phosphatidylc	rs11591147	T	G	0.017465	Phosphatidylcholines	PCSK9	1264	0	3.73732638462225e-05	0	0.999961751172849	8.75563319768429e-07	rs73015965
1	55505647	0.044772	0.00737972	1.30404e-09	417580	ebi-a-GCST90000617	rs11591147	T	G	0.018031	Serum 25-Hydroxyvitamin D levels	PCSK9							
1	55505647	-0.0847428	0.014902	1.40001e-09		met-d-Phosphoglyc	rs11591147	T	G	0.017465	Phosphoglycerides	PCSK9	1264	0	6.54577190084781e-10	0	0.999999999326292	1.91531112023377e-11	rs73015965
1	55505647	0.0450903	0.00747745	1.63783e-09	417580	ebi-a-GCST90000614	rs11591147	T	G	0.018041	Serum 25-Hydroxyvitamin D levels	PCSK9							
1	55505647	-0.0835336	0.0146982	1.29999e-08	115006	ebi-a-GCST90092937	rs11591147	T	G	0.017464	Phosphatidylcholine levels	PCSK9							
1	55505647	-0.0841679	0.0148493	1.40001e-08	115006	ebi-a-GCST90092938	rs11591147	T	G	0.017464	Phosphoglycerides levels	PCSK9							
1	55505647	-0.0261119	0.00462457	1.64051e-08	292053	ukb-a-201	rs11591147	T	G	0.0174556	Illnesses of father: Heart disease	PCSK9	1073	0	8.60951661940868e-26	0	1	6.77757608141751e-28	rs73015965
1	55505647	-0.0261119	0.00462457	1.64051e-08	292053	ukb-a-201	rs11591147	T	G	0.0174556	Illnesses of father: Heart disease	PCSK9	865	0	1.32472276006407e-42	0	1	2.92046693541649e-44	rs73015965
1	55505647	-0.189699	0.0338923	2.19999e-08	13814	ebi-a-GCST90060505	rs11591147	T	G	0.0181376	Sphingomyelin_42:3_[M+OAc]1- levels	PCSK9							
1	55505647	-0.199134	0.0361146	3.50002e-08	13814	ebi-a-GCST90060309	rs11591147	T	G	0.0181376	Sphingomyelin_34:1_[M+OAc]1- levels	PCSK9							
1	55505647	0.0432011	0.0079385	5.26926e-08	496946	ebi-a-GCST90000618	rs11591147	T	G	0.016608	Serum 25-Hydroxyvitamin D levels	PCSK9							
1	55505647	-0.0108215	0.00200545	6.69993e-08	484598	ebi-a-GCST90038605	rs11591147	T	G	0.016707	Cardiac problem	PCSK9							
1	55505647	-0.204122	0.0380408	8.09991e-08	13814	ebi-a-GCST90060370	rs11591147	T	G	0.0181376	Phosphatidylglycerol-O_38:0_[M-H]1- levels	PCSK9							
1	55505647	0.042911	0.00807024	9.09997e-08	418691	ebi-a-GCST90025967	rs11591147	T	G	0.018058	Vitamin D levels	PCSK9							
1	55505647	0.0446852	0.00844748	1.22473e-07	373045	ebi-a-GCST90014016	rs11591147	T	G		Vitamin D levels (UKB data field 30890)	PCSK9							
1	55505647	-0.174485	0.0333568	1.7e-07	13814	ebi-a-GCST90060464	rs11591147	T	G	0.0181376	Sphingomyelin_40:2_[M+OAc]1- levels	PCSK9							
1	55505647	-0.171034	0.0334828	3.29997e-07	13814	ebi-a-GCST90060470	rs11591147	T	G	0.0181376	Phosphatidylglycerol-O_42:0_[M-H]1- levels	PCSK9							
1	55505647	-0.172535	0.0344312	5.39995e-07	13814	ebi-a-GCST90060419	rs11591147	T	G	0.0181376	Phosphatidylglycerol-O_40:0_[M-H]1- levels	PCSK9							
1	55505647	-0.171084	0.0341527	5.49997e-07	13814	ebi-a-GCST90060467	rs11591147	T	G	0.0181376	Sphingomyelin_40:1_[M+OAc]1- levels	PCSK9							
1	55505647	-0.177439	0.0354919	5.80003e-07	13814	ebi-a-GCST90060409	rs11591147	T	G	0.0181376	Sphingomyelin_38:2_[M+OAc]1- levels	PCSK9							
1	55505647	0.0374828	0.00765413	5.99998e-07	437660	ebi-a-GCST90025946	rs11591147	T	G	0.0176535	Creatinine levels	PCSK9							
1	55505647	-0.1274	0.0256	6.74994e-07	153639	ebi-a-GCST90018982	rs11591147	T	G	0.0175802	Medication use (antithrombotic agents)	PCSK9							
6	161013013	-0.241623	0.0166561	6.00067e-49		met-d-LA	rs140570886	C	T	0.015497	Linoleic acid	LPA	997	0	6.78783226472695e-21	0	1.13686837721617e-16	1	rs11591147
6	161013013	-0.241198	0.0166622	1.69981e-47	115006	ebi-a-GCST90092880	rs140570886	C	T	0.015497	Linoleic acid levels	LPA							
6	161013013	0.0449768	0.0035663	1.80011e-36	426240	ukb-b-12477	rs140570886	C	T	0.015497	Illnesses of mother: Heart disease	LPA	1001	0	0.920768449900097	0	0.00572334864001729	0.0735082014598933	rs11591147
6	161013013	0.0449768	0.0035663	1.80011e-36	426240	ukb-b-12477	rs140570886	C	T	0.015497	Illnesses of mother: Heart disease	LPA	805	0	0.946073866434025	0	0.00248657179153289	0.0514395617744295	rs11591147
6	161013013	0.0516166	0.00426698	1.10002e-33	407557	ukb-b-18408	rs140570886	C	T	0.015543	Illnesses of father: Heart disease	LPA	1001	0	5.21006881745009e-05	0	6.40184520066718e-07	0.999947259127343	rs11591147
6	161013013	0.0516166	0.00426698	1.10002e-33	407557	ukb-b-18408	rs140570886	C	T	0.015543	Illnesses of father: Heart disease	LPA	830	0	3.2608149438901e-06	0	5.52208814568973e-08	0.999996683964168	rs11591147
6	161013013	0.5625	0.0472	8.25848e-33		finn-b-RX_STATIN	rs140570886	C	T	0.009302	Statin medication	LPA	991	0	2.89272014185869e-133	0	1.74880839720009e-10	0.99999999982515	rs11591147
6	161013013	0.179134	0.0161616	2.49977e-29		met-d-Unsaturation	rs140570886	C	T	0.015497	Degree of unsaturation	LPA	997	0	2.25724906750324e-07	0	3.04403710777781e-08	0.999999743834711	rs11591147
6	161013013	0.0238479	0.00213667	7.29962e-29	484598	ebi-a-GCST90038605	rs140570886	C	T	0.015371	Cardiac problem	LPA							
6	161013013	0.177925	0.0161063	2.29985e-28	115006	ebi-a-GCST90092994	rs140570886	C	T	0.015497	Degree of unsaturation	LPA	997	0	2.25724906750324e-07	0	3.04403710777781e-08	0.999999743834711	rs11591147
6	161013013	0.0227681	0.00208793	1.10002e-27	445693	ukb-b-20300	rs140570886	C	T	0.015501	Treatment speciality of consultant (recoded): Cardiology	LPA	623	0	0.578807840542	0	0.000751734308590212	0.420440425149406	rs11591147
6	161013013	0.043456	0.00410647	3.6358e-26	308780	ukb-a-209	rs140570886	C	T	0.0157148	Illnesses of mother: Heart disease	LPA	1001	0	0.920768449900097	0	0.00572334864001729	0.0735082014598933	rs11591147
6	161013013	0.043456	0.00410647	3.6358e-26	308780	ukb-a-209	rs140570886	C	T	0.0157148	Illnesses of mother: Heart disease	LPA	805	0	0.946073866434025	0	0.00248657179153289	0.0514395617744295	rs11591147
6	161013013	0.0382977	0.00372828	4.40048e-25	484598	ebi-a-GCST90038595	rs140570886	C	T	0.015371	Cardiovascular disease	LPA							
6	161013013	0.0360844	0.0035348	1.83443e-24	361194	ukb-d-IX_CIRCULATORY	rs140570886	C	T	0.0156259	Diseases of the circulatory system	LPA	1121	0	0.008704721116954	0	0.000172210057361732	0.991123068825731	rs11591147
6	161013013	0.0376033	0.00374735	4.40048e-24	477807	ebi-a-GCST90029019	rs140570886	C	T	0.015536	Cardiovascular disease	LPA							
6	161013013	0.0192662	0.00191559	8.49963e-24	461416	ukb-b-16376	rs140570886	C	T	0.015496	Main speciality of consultant (recoded): Cardiology	LPA	616	0	0.964418008585718	0	0.00129303562554252	0.0342889557887598	rs11591147
6	161013013	0.1833	0.0183	1.00207e-23	290385	ebi-a-GCST90018989	rs140570886	C	T	0.0202628	Medication use (HMG CoA reductase inhibitors)	LPA							
6	161013013	0.0479643	0.00497083	4.99459e-22	292053	ukb-a-201	rs140570886	C	T	0.0157148	Illnesses of father: Heart disease	LPA	1001	0	5.21006881745009e-05	0	6.40184520066718e-07	0.999947259127343	rs11591147
6	161013013	0.0479643	0.00497083	4.99459e-22	292053	ukb-a-201	rs140570886	C	T	0.0157148	Illnesses of father: Heart disease	LPA	830	0	3.2608149438901e-06	0	5.52208814568973e-08	0.999996683964168	rs11591147
6	161013013	0.016234	0.00170433	1.65844e-21	337159	ukb-a-176	rs140570886	C	T	0.0157148	Treatment/medication code: atorvastatin	LPA	1001	0	6.75787358433206e-10	0	2.29190985553005e-10	0.999999999095053	rs11591147
6	161013013	0.016234	0.00170433	1.65844e-21	337159	ukb-a-176	rs140570886	C	T	0.0157148	Treatment/medication code: atorvastatin	LPA	564	3.82953674922892e-88	0.0036243585732606	1.04975968005795e-85	0.993512997217254	0.00286264420947621	rs472495
6	161013013	-0.155807	0.0169144	6.59933e-21		met-d-GlycA	rs140570886	C	T	0.015487	Glycoprotein acetyls	LPA	997	0	0.965562421566327	0	0.0237254891966314	0.0107120892370591	rs11591147
6	161013013	-0.141198	0.0160933	8.19974e-20		met-d-Phosphoglyc	rs140570886	C	T	0.015497	Phosphoglycerides	LPA	997	0	1.08486161437497e-05	0	7.66079154619193e-07	0.999988385304653	rs11591147
6	161013013	-0.151061	0.0167939	2.39994e-19	115082	ebi-a-GCST90092821	rs140570886	C	T	0.015486	Glycoprotein acetyls levels	LPA							
6	161013013	0.0134246	0.00149322	2.47571e-19	336683	ukb-a-434	rs140570886	C	T	0.0157148	Vascular/heart problems diagnosed by doctor: Heart attack	LPA	1001	0	0.403474693683709	0	0.00183317950181049	0.594692126814429	rs11591147
6	161013013	0.0134246	0.00149322	2.47571e-19	336683	ukb-a-434	rs140570886	C	T	0.0157148	Vascular/heart problems diagnosed by doctor: Heart attack	LPA	550	1.05463472739888e-85	0.998129062504974	1.26581939587376e-88	0.00119732517729187	0.000673612317730915	rs472495
6	161013013	-0.139681	0.0160371	2.99985e-18	115006	ebi-a-GCST90092938	rs140570886	C	T	0.015497	Phosphoglycerides levels	LPA							
6	161013013	0.0767766	0.00894062	1.10002e-17	415311	ebi-a-GCST006701	rs140570886	C	T	0.015533	Parental longevity (father's attained age)	LPA							
6	161013013	0.0762979	0.00920285	1.20005e-16	389166	ebi-a-GCST006697	rs140570886	C	T	0.015518	Parental longevity (combined parental attained age, Martingale residuals)	LPA							
6	161013013	0.02413	0.00297048	4.49987e-16	457547	ukb-b-7137	rs140570886	C	T	0.015484	Medication for pain relief, constipation, heartburn: Aspirin	LPA	765	0	0.0229968707475805	0	0.00209271413372452	0.974910415118739	rs11591147
6	161013013	0.023384	0.00288446	5.19996e-16	462933	ukb-b-8755	rs140570886	C	T	0.015491	Treatment/medication code: aspirin	LPA	1001	0	0.881484198872382	0	0.00464567684072505	0.113870124286897	rs11591147
6	161013013	0.023384	0.00288446	5.19996e-16	462933	ukb-b-8755	rs140570886	C	T	0.015491	Treatment/medication code: aspirin	LPA	756	0	0.110829748791772	0	0.00524851677394446	0.883921734434257	rs11591147
6	161013013	-0.12372	0.0159797	1.39991e-15		met-d-Cholines	rs140570886	C	T	0.015497	Total cholines	LPA	997	0	1.09013010267761e-10	0	1.01190613004161e-10	0.999999999789793	rs11591147
6	161013013	0.0212012	0.00269375	3.50026e-15	462933	ukb-b-11268	rs140570886	C	T	0.015491	Treatment/medication code: simvastatin	LPA	1001	0	4.62784519039613e-22	0	0	1	rs11591147
6	161013013	0.0212012	0.00269375	3.50026e-15	462933	ukb-b-11268	rs140570886	C	T	0.015491	Treatment/medication code: simvastatin	LPA	690	0	9.6252325470067e-29	0	0	1	rs11591147
6	161013013	-0.122482	0.0159495	1.59993e-14	115006	ebi-a-GCST90092812	rs140570886	C	T	0.015497	Total cholines levels	LPA							
6	161013013	-0.0734269	0.00979131	6.4003e-14	341118	ukb-b-11303	rs140570886	C	T	0.015769	Father's age at death	LPA							
6	161013013	-0.113051	0.0159214	1.10002e-13		met-d-Phosphatidylc	rs140570886	C	T	0.015497	Phosphatidylcholines	LPA	997	0	9.08596524094412e-06	0	7.13063118260367e-07	0.999990200971673	rs11591147
6	161013013	0.00560813	0.000766184	2.49345e-13	337159	ukb-a-191	rs140570886	C	T	0.0157148	Treatment/medication code: ezetimibe	LPA	1001	0	0.0247253966641136	0	0.000100938815382957	0.975173664520538	rs11591147
6	161013013	0.00560813	0.000766184	2.49345e-13	337159	ukb-a-191	rs140570886	C	T	0.0157148	Treatment/medication code: ezetimibe	LPA	405	1.05295301446673e-85	0.996525103987904	2.01221962855974e-89	0.000187150702279646	0.0032877453098193	rs472495
6	161013013	-0.318196	0.0439376	4.42079e-13	19757	eqtl-a-ENSG00000175003	rs140570886	C	T	0.0186283	ENSG00000175003	LPA	5	0	0.981239982947332	0	4.04557876096592e-05	0.0187195612650723	rs11591147
6	161013013	0.0241125	0.00336806	8.13205e-13	337159	ukb-a-132	rs140570886	C	T	0.0157148	Treatment/medication code: aspirin	LPA	1001	0	0.881484198872382	0	0.00464567684072505	0.113870124286897	rs11591147
6	161013013	0.0241125	0.00336806	8.13205e-13	337159	ukb-a-132	rs140570886	C	T	0.0157148	Treatment/medication code: aspirin	LPA	756	0	0.110829748791772	0	0.00524851677394446	0.883921734434257	rs11591147
6	161013013	-0.11202	0.0158771	1.69981e-12	115006	ebi-a-GCST90092937	rs140570886	C	T	0.015497	Phosphatidylcholine levels	LPA							
6	161013013	0.0240973	0.00346013	3.30674e-12	333581	ukb-a-452	rs140570886	C	T	0.0157148	Medication for pain relief  constipation  heartburn: Aspirin	LPA	1001	0	0.570014546260985	0	0.00354873567838664	0.426436718060654	rs11591147
6	161013013	0.0196688	0.00295018	2.60016e-11	363542	ukb-b-14371	rs140570886	C	T	0.015467	Illnesses of siblings: Heart disease	LPA	1001	0	0.981399557186285	0	0.0117130895448795	0.00688735326886315	rs11591147
6	161013013	0.0196688	0.00295018	2.60016e-11	363542	ukb-b-14371	rs140570886	C	T	0.015467	Illnesses of siblings: Heart disease	LPA	664	0	0.358943841394249	0	0.38406393289169	0.256992225714023	rs11591147
6	161013013	0.0209651	0.00315582	3.07185e-11	337159	ukb-a-121	rs140570886	C	T	0.0157148	Treatment/medication code: simvastatin	LPA	1001	0	4.62784519039613e-22	0	0	1	rs11591147
6	161013013	0.0209651	0.00315582	3.07185e-11	337159	ukb-a-121	rs140570886	C	T	0.0157148	Treatment/medication code: simvastatin	LPA	690	0	9.6252325470067e-29	0	0	1	rs11591147
6	161013013	-0.0293054	0.00443348	3.80014e-11	402586	ukb-b-15169	rs140570886	C	T	0.015487	Illnesses of father: None of the above (group 1)	LPA	1001	0	0.935817338227634	0	0.00772708969848587	0.0564555720738362	rs11591147
6	161013013	-0.0293054	0.00443348	3.80014e-11	402586	ukb-b-15169	rs140570886	C	T	0.015487	Illnesses of father: None of the above (group 1)	LPA	838	0	0.634800589470501	0	0.00426530750177823	0.360934103027775	rs11591147
6	161013013	0.2136	0.0328	7.68776e-11	977323	ebi-a-GCST009541	rs140570886	C	T		Heart failure	LPA							
6	161013013	-0.0246208	0.00384575	1.5e-10	461880	ukb-b-13352	rs140570886	C	T	0.015495	Vascular/heart problems diagnosed by doctor: None of the above	LPA	1001	0	0.987693734054535	0	0.00651637780667214	0.00578988813884162	rs11591147
6	161013013	-0.0246208	0.00384575	1.5e-10	461880	ukb-b-13352	rs140570886	C	T	0.015495	Vascular/heart problems diagnosed by doctor: None of the above	LPA	877	0	0.987854158895089	0	0.00461700882470263	0.00752883228018532	rs11591147
6	161013013	0.042793	0.0068161	3.40001e-10	462933	ukb-b-3656	rs140570886	C	T	0.015491	Number of treatments/medications taken	LPA							
6	161013013	0.0167809	0.00274082	9.20005e-10	463010	ukb-b-12493	rs140570886	C	T	0.015491	Diagnoses - secondary ICD10: I10 Essential (primary) hypertension	LPA	702	0	0.997849117626308	0	0.000879052621002045	0.00127182975269497	rs11591147
6	161013013	0.0414834	0.00685029	1.40001e-09	144817	ukb-b-19722	rs140570886	C	T	0.015292	Non-accidental death in close genetic family	LPA	1001	0	0.948456490084569	0	0.0110143212596352	0.0405291886558469	rs11591147
6	161013013	0.0414834	0.00685029	1.40001e-09	144817	ukb-b-19722	rs140570886	C	T	0.015292	Non-accidental death in close genetic family	LPA	669	0	0.745514517973439	0	0.00195494316331389	0.252530538863227	rs11591147
6	161013013	-0.068364	0.0114253	2.18625e-09	248726	ukb-a-41	rs140570886	C	T	0.0157148	Father's age at death	LPA							
6	161013013	0.1122	0.0189	2.81903e-09	153639	ebi-a-GCST90018982	rs140570886	C	T	0.022302	Medication use (antithrombotic agents)	LPA							
6	161013013	0.04709	0.00798182	3.64594e-09	337159	ukb-a-24	rs140570886	C	T	0.0157148	Number of treatments/medications taken	LPA							
6	161013013	0.3375	0.0572	3.69301e-09		finn-b-I9_CVD_HARD	rs140570886	C	T	0.009302	Hard cardiovascular diseases	LPA	991	0	0.00172518121346747	0	0.00305697080953577	0.995217847977047	rs11591147
6	161013013	0.019054	0.00333943	1.15936e-08	259921	ukb-a-217	rs140570886	C	T	0.0157148	Illnesses of siblings: Heart disease	LPA	1001	0	0.981399557186285	0	0.0117130895448795	0.00688735326886315	rs11591147
6	161013013	0.019054	0.00333943	1.15936e-08	259921	ukb-a-217	rs140570886	C	T	0.0157148	Illnesses of siblings: Heart disease	LPA	664	0	0.358943841394249	0	0.38406393289169	0.256992225714023	rs11591147
6	161013013	0.00450095	0.000792446	1.34946e-08	337159	ukb-a-180	rs140570886	C	T	0.0157148	Treatment/medication code: clopidogrel	LPA	1001	0	0.702952770991975	0	0.296041219580768	0.00100600942728496	rs11591147
6	161013013	0.0390258	0.00702621	2.80001e-08	462933	ukb-b-4063	rs140570886	C	T	0.015491	Number of self-reported non-cancer illnesses	LPA							
6	161013013	-0.0737751	0.0133774	3.40001e-08	208118	ebi-a-GCST006702	rs140570886	C	T	0.015677	Parental longevity (combined parental age at death)	LPA							
6	161013013	0.3102	0.0568	4.78002e-08		finn-b-E4_METABOLIA	rs140570886	C	T	0.009302	Metabolic disorders	LPA	991	0	3.3548913847058e-15	0	3.77550854277364e-08	0.999999962244943	rs11591147
6	161013013	0.2444	0.0457	9.1791e-08	465527	ebi-a-GCST90018811	rs140570886	C	T	0.0178597	Cardiac valvular disease	LPA							
6	161013013	0.4925	0.0924	9.75192e-08		finn-b-Z21_PRESENCE_CARDIAC_VASCULAR_IMPLANTNTS_GRAFTS	rs140570886	C	T	0.00933	Presence of cardiac and vascular implants and grafts	LPA	991	0	0.0943993303446517	0	0.00747249856660778	0.89812817108873	rs11591147
6	161013013	0.0478619	0.00899005	1e-07	412937	ebi-a-GCST006696	rs140570886	C	T	0.015527	Parental longevity (mother's attained age)	LPA							
6	161013013	-0.022075	0.00426276	2.19999e-07	457547	ukb-b-11085	rs140570886	C	T	0.015484	Medication for pain relief, constipation, heartburn: None of the above	LPA	870	0	0.931534292896921	0	0.00577248488239893	0.0626932222207361	rs11591147
6	161013013	-0.0553559	0.0109152	3.89996e-07	317652	ebi-a-GCST006700	rs140570886	C	T	0.015458	Parental longevity (father's age at death)	LPA							
6	161013013	0.0407556	0.00822133	7.15122e-07	337159	ukb-a-22	rs140570886	C	T	0.0157148	Number of self-reported non-cancer illnesses	LPA							
6	161013013	-0.022508	0.00454532	7.35258e-07	336683	ukb-a-435	rs140570886	C	T	0.0157148	Vascular/heart problems diagnosed by doctor: None of the above	LPA	1001	0	0.987693734054535	0	0.00651637780667214	0.00578988813884162	rs11591147
6	161013013	-0.022508	0.00454532	7.35258e-07	336683	ukb-a-435	rs140570886	C	T	0.0157148	Vascular/heart problems diagnosed by doctor: None of the above	LPA	877	0	0.987854158895089	0	0.00461700882470263	0.00752883228018532	rs11591147
6	161013013	-0.0245653	0.00498328	8.2467e-07	333581	ukb-a-453	rs140570886	C	T	0.0157148	Medication for pain relief  constipation  heartburn: None of the above	LPA	1001	0	0.978775393386998	0	0.0120099266417973	0.00921467997121111	rs11591147
6	160911596	0.3414	0.0574	2.79898e-09		finn-b-I9_CVD_HARD	rs147555597	A	G	0.009326	Hard cardiovascular diseases	LPA	991	0	0.00172518121346747	0	0.00305697080953577	0.995217847977047	rs11591147
6	160911596	0.0650625	0.0116789	2.39999e-08	389166	ebi-a-GCST006697	rs147555597	A	G	0.00956	Parental longevity (combined parental attained age, Martingale residuals)	LPA							
6	160911596	-0.117354	0.021125	2.80001e-08	115006	ebi-a-GCST90092880	rs147555597	A	G	0.009556	Linoleic acid levels	LPA							
6	160911596	-0.118532	0.0211174	3.50002e-08		met-d-LA	rs147555597	A	G	0.009556	Linoleic acid	LPA	997	0	6.78783226472695e-21	0	1.13686837721617e-16	1	rs11591147
6	160911596	0.0257405	0.00476679	3.89996e-08	477807	ebi-a-GCST90029019	rs147555597	A	G	0.009523	Cardiovascular disease	LPA							
6	160911596	0.0298602	0.00543982	4e-08	407557	ukb-b-18408	rs147555597	A	G	0.009478	Illnesses of father: Heart disease	LPA	1001	0	5.21006881745009e-05	0	6.40184520066718e-07	0.999947259127343	rs11591147
6	160911596	0.0298602	0.00543982	4e-08	407557	ukb-b-18408	rs147555597	A	G	0.009478	Illnesses of father: Heart disease	LPA	830	0	3.2608149438901e-06	0	5.52208814568973e-08	0.999996683964168	rs11591147
6	160911596	0.0241539	0.00447914	6.95168e-08	361194	ukb-d-IX_CIRCULATORY	rs147555597	A	G	0.00962662	Diseases of the circulatory system	LPA	1121	0	0.008704721116954	0	0.000172210057361732	0.991123068825731	rs11591147
6	160911596	0.0584798	0.0113373	2.1e-07	415311	ebi-a-GCST006701	rs147555597	A	G	0.009574	Parental longevity (father's attained age)	LPA							
6	160911596	0.0186186	0.00375168	6.9536e-07	360294	ukb-d-1538_1	rs147555597	A	G	0.00963039	Major dietary changes in the last 5 years: Yes, because of illness	LPA	1121	0	0.133875425692314	0	0.861937134213514	0.00418744009421756	rs11591147
6	161123451	0.026214	0.0017899	1.39991e-48	407557	ukb-b-18408	rs4252185	C	T	0.099175	Illnesses of father: Heart disease	PLG							
6	161123451	0.1231	0.0099	2.69526e-35	290385	ebi-a-GCST90018989	rs4252185	C	T	0.0913332	Medication use (HMG CoA reductase inhibitors)	PLG							
6	161123451	0.0243878	0.00206855	4.47816e-32	292053	ukb-a-201	rs4252185	C	T	0.102146	Illnesses of father: Heart disease	PLG							
6	161123451	0.2129	0.0187	3.78443e-30		finn-b-RX_STATIN	rs4252185	C	T	0.0623	Statin medication	PLG							
6	161123451	0.00673958	0.00060958	1.99986e-28	462933	ukb-b-10008	rs4252185	C	T	0.099101	Treatment/medication code: atorvastatin	PLG							
6	161123451	0.00969888	0.000905246	8.00018e-27	484598	ebi-a-GCST90038605	rs4252185	C	T	0.095418	Cardiac problem	PLG							
6	161123451	0.0158702	0.00149358	2.29985e-26	426240	ukb-b-12477	rs4252185	C	T	0.09921	Illnesses of mother: Heart disease	PLG							
6	161123451	0.00562048	0.000536646	1.10002e-25	461880	ukb-b-11590	rs4252185	C	T	0.099077	Vascular/heart problems diagnosed by doctor: Heart attack	PLG							
6	161123451	0.0125257	0.00123462	3.50026e-24	363542	ukb-b-14371	rs4252185	C	T	0.09906	Illnesses of siblings: Heart disease	PLG							
6	161123451	0.0666448	0.00674854	1.50003e-23		met-d-Unsaturation	rs4252185	C	T	0.099687	Degree of unsaturation	PLG							
6	161123451	0.0663572	0.0067253	5.79963e-23	115006	ebi-a-GCST90092994	rs4252185	C	T	0.099686	Degree of unsaturation	PLG							
6	161123451	0.0161958	0.00170487	2.11885e-21	308780	ukb-a-209	rs4252185	C	T	0.102146	Illnesses of mother: Heart disease	PLG							
6	161123451	0.00769253	0.000874314	1.39991e-18	445693	ukb-b-20300	rs4252185	C	T	0.099199	Treatment speciality of consultant (recoded): Cardiology	PLG							
6	161123451	0.0128093	0.00147221	3.31055e-18	361194	ukb-d-IX_CIRCULATORY	rs4252185	C	T	0.101344	Diseases of the circulatory system	PLG							
6	161123451	0.00616353	0.00070859	3.38376e-18	337159	ukb-a-176	rs4252185	C	T	0.102146	Treatment/medication code: atorvastatin	PLG							
6	161123451	-0.0607147	0.007061	9.3994e-18		met-d-GlycA	rs4252185	C	T	0.099681	Glycoprotein acetyls	PLG							
6	161123451	0.0118997	0.00138679	9.47764e-18	259921	ukb-a-217	rs4252185	C	T	0.102146	Illnesses of siblings: Heart disease	PLG							
6	161123451	-0.0579901	0.00695504	1.29987e-17		met-d-LA	rs4252185	C	T	0.099687	Linoleic acid	PLG							
6	161123451	-0.0595721	0.00701065	1.9002e-17	115082	ebi-a-GCST90092821	rs4252185	C	T	0.099677	Glycoprotein acetyls levels	PLG							
6	161123451	-0.0579453	0.00695739	8.19974e-17	115006	ebi-a-GCST90092880	rs4252185	C	T	0.099686	Linoleic acid levels	PLG							
6	161123451	0.00513116	0.000621094	1.44378e-16	336683	ukb-a-434	rs4252185	C	T	0.102146	Vascular/heart problems diagnosed by doctor: Heart attack	PLG							
6	161123451	0.00643512	0.000802399	1.10002e-15	461416	ukb-b-16376	rs4252185	C	T	0.099107	Main speciality of consultant (recoded): Cardiology	PLG							
6	161123451	0.00349825	0.000448262	6.00067e-15	463010	ukb-b-9592	rs4252185	C	T	0.099094	Operative procedures - main OPCS: K63.3 Angiocardiography of left side of heart NEC	PLG							
6	161123451	0.0120011	0.00157957	2.29985e-14	484598	ebi-a-GCST90038595	rs4252185	C	T	0.095418	Cardiovascular disease	PLG							
6	161123451	-0.0138068	0.00185784	1.10002e-13	402586	ukb-b-15169	rs4252185	C	T	0.098998	Illnesses of father: None of the above (group 1)	PLG							
6	161123451	-0.0234942	0.00341891	1.10002e-13	397043	ebi-a-GCST90025958	rs4252185	C	T	0.0998942	Sex hormone-binding globulin levels	PLG							
6	161123451	0.00866484	0.00120806	7.39946e-13	462933	ukb-b-8755	rs4252185	C	T	0.099101	Treatment/medication code: aspirin	PLG							
6	161123451	0.00885998	0.00124375	1.10002e-12	457547	ukb-b-7137	rs4252185	C	T	0.099096	Medication for pain relief, constipation, heartburn: Aspirin	PLG							
6	161123451	-0.0152305	0.00214846	1.35363e-12	292053	ukb-a-202	rs4252185	C	T	0.102146	Illnesses of father: None of the above (group 1)	PLG							
6	161123451	0.0101117	0.00143866	2.09122e-12	333581	ukb-a-452	rs4252185	C	T	0.102146	Medication for pain relief  constipation  heartburn: Aspirin	PLG							
6	161123451	0.1578	0.0227	3.83089e-12		finn-b-I9_CVD_HARD	rs4252185	C	T	0.0623	Hard cardiovascular diseases	PLG							
6	161123451	0.00953199	0.00140028	9.96782e-12	337159	ukb-a-132	rs4252185	C	T	0.102146	Treatment/medication code: aspirin	PLG							
6	161123451	0.00259433	0.000385019	1.59993e-11	461137	ukb-b-11247	rs4252185	C	T	0.099088	Main speciality of consultant (recoded): Cardiothoracic surgery	PLG							
6	161123451	0.0103315	0.00157157	2.39994e-11	477807	ebi-a-GCST90029019	rs4252185	C	T	0.099417	Cardiovascular disease	PLG							
6	161123451	0.0791	0.0119	2.83074e-11	153639	ebi-a-GCST90018982	rs4252185	C	T	0.0923421	Medication use (antithrombotic agents)	PLG							
6	161123451	0.025377	0.00384068	3.50026e-11	389166	ebi-a-GCST006697	rs4252185	C	T	0.100248	Parental longevity (combined parental attained age, Martingale residuals)	PLG							
6	161123451	0.00208312	0.000318547	6.18301e-11	337159	ukb-a-191	rs4252185	C	T	0.102146	Treatment/medication code: ezetimibe	PLG							
6	161123451	0.00482577	0.000750882	1.29999e-10	462933	ukb-b-11895	rs4252185	C	T	0.099101	Treatment/medication code: ramipril	PLG							
6	161123451	0.2337	0.0365	1.49599e-10		finn-b-Z21_PRESENCE_CARDIAC_VASCULAR_IMPLANTNTS_GRAFTS	rs4252185	C	T	0.06225	Presence of cardiac and vascular implants and grafts	PLG							
6	161123451	-0.1458	0.023	2.31798e-10	10708	ebi-a-GCST90019437	rs4252185	C	T	0.0964	Angiostatin measurement	PLG							
6	161123451	0.00217958	0.000345542	2.80001e-10	444235	ukb-b-6951	rs4252185	C	T	0.099178	Treatment speciality of consultant (recoded): Cardiothoracic surgery	PLG							
6	161123451	0.00702842	0.00112819	4.70002e-10	462933	ukb-b-11268	rs4252185	C	T	0.099101	Treatment/medication code: simvastatin	PLG							
6	161123451	-0.0209122	0.00364147	2.5e-09	400938	ebi-a-GCST90025992	rs4252185	C	T	0.0999509	Serum albumin levels	PLG							
6	161123451	0.1074	0.0181	2.70901e-09		finn-b-DM_COMORB_EXMORE	rs4252185	C	T	0.0625	Diabetes-related co-morbidities/complications (more controls excluded)	PLG							
6	161123451	-0.00763593	0.00143826	3.79997e-09	368929	ebi-a-GCST90012110	rs4252185	C	T	0.100128	Sex hormone-binding globulin levels adjusted for BMI	PLG							
6	161123451	0.195	0.0338	8.02103e-09	242659	ebi-a-GCST90018983	rs4252185	C	T	0.0916541	Medication use (vasodilators used in cardiac diseases)	PLG							
6	161123451	0.00133801	0.000233882	1.06062e-08	361194	ukb-d-I9_PAD	rs4252185	C	T	0.101344	Peripheral artery disease	PLG							
6	161123451	0.0212682	0.00373211	1.09999e-08	415311	ebi-a-GCST006701	rs4252185	C	T	0.10027	Parental longevity (father's attained age)	PLG							
6	161123451	0.00743254	0.00131206	1.47316e-08	337159	ukb-a-121	rs4252185	C	T	0.102146	Treatment/medication code: simvastatin	PLG							
6	161123451	0.1901	0.034	2.15899e-08	483078	ebi-a-GCST90018890	rs4252185	C	T	0.0904429	Peripheral artery disease	PLG							
6	161123451	-0.00798206	0.00160272	3.09999e-08	370125	ebi-a-GCST90012111	rs4252185	C	T	0.100135	Sex hormone-binding globulin levels	PLG							
6	161123451	0.0813	0.0152	9.59511e-08	977323	ebi-a-GCST009541	rs4252185	C	T		Heart failure	PLG							
6	161123451	-0.00857559	0.0016111	1e-07	461880	ukb-b-13352	rs4252185	C	T	0.099077	Vascular/heart problems diagnosed by doctor: None of the above	PLG							
6	161123451	0.0199683	0.00375169	1e-07	412937	ebi-a-GCST006696	rs4252185	C	T	0.100223	Parental longevity (mother's attained age)	PLG							
6	161123451	0.4381	0.08288	1.253e-07		ukb-e-104410_AFR	rs4252185	C	T	0.98554	Stewed fruit intake	PLG							
6	161123451	0.00174069	0.000329462	1.26862e-07	337159	ukb-a-180	rs4252185	C	T	0.102146	Treatment/medication code: clopidogrel	PLG							
6	161123451	0.00713287	0.00136114	1.6e-07	461894	ukb-b-15784	rs4252185	C	T	0.099101	Main speciality of consultant (recoded): General medicine	PLG							
6	161123451	-0.00983554	0.00188762	1.89998e-07	364971	ukb-b-17360	rs4252185	C	T	0.09904	Illnesses of siblings: None of the above (group 1)	PLG							
6	161123451	0.0721	0.0139	2.17901e-07	112010	ebi-a-GCST90018995	rs4252185	C	T	0.0931419	Medication use (salicylic acid and derivatives)	PLG							
6	161123451	-0.0173735	0.00336539	2.43809e-07	354620	ebi-a-GCST90014011	rs4252185	C	T		Sex hormone binding globulin levels (UKB data field 30830)	PLG							
6	161123451	-0.00941259	0.00212326	3.09999e-07	188908	ebi-a-GCST90012106	rs4252185	C	T	0.100217	Sex hormone-binding globulin levels adjusted for BMI	PLG							
6	161123451	0.00444513	0.000873974	3.65671e-07	337159	ukb-a-117	rs4252185	C	T	0.102146	Treatment/medication code: ramipril	PLG							
6	161123451	0.0515637	0.0101765	4.53336e-07	407746	ebi-a-GCST90013912	rs4252185	C	T		Chest pain or discomfort (UKB data field 2335) (Firth correction)	PLG							
6	161123451	0.0519913	0.0103105	4.59325e-07	407746	ebi-a-GCST90013962	rs4252185	C	T		Chest pain or discomfort (UKB data field 2335) (SPA correction)	PLG							
6	161123451	0.0164977	0.00329139	5.38431e-07	105569	ukb-a-366	rs4252185	C	T	0.102146	Non-accidental death in close genetic family	PLG							
6	161123451	-0.00966106	0.0019319	5.71176e-07	360291	ukb-d-1428_1	rs4252185	C	T	0.101344	Spread type: Butter/spreadable butter	PLG							
6	161123451	-0.0141862	0.00312769	6.59994e-07	444866	ebi-a-GCST90025951	rs4252185	C	T	0.100121	Platelet count	PLG							
